The Albanese Government’s 10-Year Dementia Action Plan is aiming for greater public awareness of dementia, and excellent post-diagnostic support for those living with the condition, as well as their carers. However, many in the sector are concerned that it fails to address a range of royal commission rcommendations, particularly in regards to human rights of people living with dementia. BIANCA ROBERTS spoke to several leading advocacy body heads.
A large international study of dementia risk involving almost 30,000 people from 18 countries covering all six continents suggests that social and economic disadvantage may explain the higher risk of the condition in women.
Dementia affects a far higher proportion of CALD elders than those born in Australia, yet mainstream providers and workers continue to make little allowance for the unique needs of these elders. NARI's Professor Bianca Brijnath, offers a number of practical tips and strategies for the road ahead, spearheaded by clear lines of communication and a willingness to listen and learn from diverse communities. BIANCA ROBERTS reports
Returning to the Adelaide Fringe Festival 2023 from March 7-19, The Fishbowl is a fabulous one-hour experimental theatre performance inspired by actor, aged care worker and writer Matthew Barker's personal diary entries from 2016 while working in a memory support unit. New audio has been added for the 2023 iteration of the play, comprising interview material from experts, other aged care workers and family members of those with lived experience of dementia. BIANCA ROBERTS reports
Since 2018, Opal Healthcare CEO Rachael Argaman and director of communications and sustainability, Roseanne Cartwright, have been overseeing a transformation of Opal Healthcare aged care facilities nationwide. BIANCA ROBERTS reports
Scientists from CSIRO, in partnership with Queensland University of Technology, have used artificial intelligence to develop a world-first benchmark for measuring brain atrophy – or thinning – in neurodegenerative diseases, including Alzheimer’s disease.
The Pharmaceutical Society of Australia has announced the election of Dr Amy Page as president of its Victorian branch. Page's research and clinical practice focuses on older people with multimorbidity, polypharmacy and dementia.
Dementia Australia says it welcomes the announcement by the United States Food and Drug Administration approving 'lecanemab', a new disease modifying treatment for people living with the early stages of Alzheimer’s disease or mild cognitive impairment.